NanoFUSE DBM is the company’s proprietary bone void filler product. Specifically, it has been cleared for use with autograft as a bone graft extender in the posterolateral spine. It is the first off-the-shelf DBM product containing bioactive glass available for use in an orthopedic clinical setting.
More articles on devices:
Amedica brings on with PCG Advisory as agency of record
OrthoWorx commits $475k on workforce development — 6 initiatives
Mesoblast gets patent for mesenchymal precursor cell technology — 7 thing to know
